Hepatocellular carcinoma (HCC) mortality rates are increasing globally, and particularly in
the Western world. Cirrhosis remains the predominant risk factor for HCC. However …

Abdominal US is currently the best-validated surveillance strategy for hepatocellular
carcinoma (HCC) in at-risk patients. It is the only modality shown to have completed all five …

Background & Aims Hepatocellular carcinoma (HCC) surveillance is associated with
improved early detection and reduced mortality, although practice patterns and effectiveness …

Liver transplantation (LT) is lifesaving for patients with cirrhosis; however, the resultant
financial burden to patients has not been well characterized. We aimed to provide a …

Importance Cohort studies demonstrating an association of hepatocellular carcinoma (HCC)
screening with reduced mortality are prone to lead-time and length-time biases. Objective To …

Introduction: Given suboptimal performance of ultrasound-based surveillance for early
hepatocellular carcinoma (HCC) detection in patients with cirrhosis, there is interest in …

Background The value of hepatocellular carcinoma (HCC) screening is defined by the
balance of benefits from early tumor detection vs harms due to false positive results. We …

Background: The original hepatocellular carcinoma early detection screening (HES) score,
which combines alpha-fetoprotein (AFP) with age, alanine aminotransferase, and platelets …

Background: Hepatocellular carcinoma (HCC) surveillance is associated with improved
early tumor detection, but effectiveness is limited by underuse. We characterized adherence …

Racial, ethnic, and socioeconomic disparities exist in the prevalence and natural history of
chronic liver disease, access to care, and clinical outcomes. Solutions to improve health …